GlassScriptPhysician profile
Francesca Bryn Walker
NPI 1306574595
$8,441.92
in general payments reported to CMS, 2019-2025
21 companies · $2,863 in 2025
The $2,863 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $298 · 2023: $2,135 · 2024: $3,145 · 2025: $2,863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,021 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,020.84 |
| Education | $122.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,532.27 | 2022-2025 | Tremfya |
| Ucb, INC. | $1,119.15 | 2022-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $726.19 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $682.11 | 2022-2024 | Sotyktu |
| Incyte Corporation | $647.37 | 2023-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $645.17 | 2023-2025 | |
| Pfizer INC. | $523.30 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $447.28 | 2022-2025 | Ilumya, Absorica Ld, Winlevi |
| Lilly USA, LLC | $433.70 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $351.24 | 2023-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $254.31 | 2024-2025 | Nemluvio, Aklief |
| Dermavant Sciences, INC. | $230.47 | 2023-2024 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.14 | 2022-2025 | Spevigo, Cyltezo |
| Regeneron Healthcare Solutions, INC. | $140.01 | 2023-2025 | Dupixent |
| Genzyme Corporation | $131.04 | 2024-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $101.24 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $95.36 | 2022-2025 | Jublia, Cabtreo, Arazlo |
| Organon LLC | $90.99 | 2025 | Nexplanon, Vtama |
| Blueprint Medicines Corporation | $46.50 | 2025 | Ayvakit |
| Verrica Pharmaceuticals INC. | $19.90 | 2023 | Ycanth |
| Leo Pharma INC. | $17.18 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francesca Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.